Low plasma levels of oxidized low density lipoprotein in preeclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 12, 2004, Pages 1173-1177

  Raijmakers, Maarten T M ^a,c   Van Tits, Berry J H ^a   Hak Lemmers, Heidi L M ^a   Roes, Eva Maria ^a   Steegers, Eric A P ^b   Peters, Wilbert H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Oxidized low density lipoprotein; Preeclampsia; TBARS

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GESTATIONAL AGE; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; OXIDATIVE STRESS; PREECLAMPSIA; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 10344239416     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00539.x     Document Type: Article

References (27)

1. Williams DJ, de Swiet M. The pathophysiology of pre-eclampsia. Intensive Care Med 1997; 23: 620-9.
2. Lindheimer MD, Katz AI. Preeclampsia: pathophysiology, diagnosis, and management. Annu Rev Med 1989; 40: 233-50.
3. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222: 222-35.
4. Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 1998; 16: 65-73.
5. Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol 1996; 103: 614-20.
6. Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 1999; 13: 347-52.
7. Buhimschi IA, Weiner CP. Oxygen free radicals and disorders of pregnancy. Fetal Matern Med Rev 2002; 12: 273-98.
8. Sagol S, Ozkinay E, Ozsener S. Impaired antioxidant activity in women with pre-eclampsia. Int J Gynaecol Obstet 1999; 64: 121-7.
9. Gratacos E. Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. Eur J Obstet Gynecol Reprod Biol 2000; 92: 63-6.
10. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, Mclaughlin MK. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989; 161: 1025-34.
11. Raijmakers MTM, Peters WHM, Steegers EAP, Poston L. Amino thiols, detoxification and oxidative stress in pre-eclampsia and other disorders of pregnancy. Curr Pharm Des (in press).
12. Hubel CA, Shakir Y, Gallaher MJ, McLaughlin MK, Roberts JM. Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increases. J Soc Gynecol Invest 1998; 5: 244-50.
13. Rosing U, Samsioe G, Olund A, Johansson B, Kallner A. Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia. Horm Metab Res 1989; 21: 376-82.
14. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174: 975-82.
15. Wang J, Mimuro S, Lahoud R, Trudinger B, Wang XL. Elevated levels of lipoprotein (a) in women with preeclampsia. Am J Obstet Gynecol 1998; 178: 146-9.
16. Wakatsuki A, Ikenoue N, Okatani Y, Shinohara K, Fukaya T. Lipoprotein particles in preeclampsia: susceptibility to oxidative modification. Obstet Gynecol 2000; 96: 55-9.
17. Conti M, Morand PC, Levillain P, Lemonnier A. Improved fluorometric determination of malonaldehyde. Clin Chem 1991; 37: 1273-5.
18. Van Tits LJH, de Waart F, Hak-Lemmers HLM, van Heijst P, de Graaf J et al. Effects of alpha-tocopherol on Superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Radic Biol Med 2001; 30: 1122-9.
19. Van den Akker JM, Bredie SJH, Diepenveen SHA, Van Tits LJH, Stalenhoef AFH, Van Leusen R. Atorvastatin and simvastatin in patients on hemodialysis. effects on lipoproteins, C-reactive protein and in vivo oxidized LDL. J Nephrol 2003; 16: 238-44.
20. Gratacos E, Casals E, Deulofeu R, Gomez O, Cararach V, Alonso PL et al. Serum antibodies to oxidized low-density lipoprotein in pregnant women with preeclampsia and chronic hypertension: lack of correlation with lipid peroxides. Hypertens Pregnancy 2001; 20: 177-83.
21. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe pre-eclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 2001; 15: 279-81.
22. Pierucci F, Piazze Garnica JJ, Cosmi EV, Anceschi MM. Oxidability of low density lipoproteins in pregnancy-induced hypertension. Br J Obstet Gynaecol 1996; 103: 1159-61.
23. Fruebis J, Bird DA, Pattison J, Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res 1997; 38: 2455-64.
24. Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclampsia pregnancies. Br J Obstet Gynaecol 1998; 105: 1113-17.
25. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 1994; 343: 645-6.
26. Armstrong V, Wieland E, Diedrich F, Renner A, Rath W, Kreuzer H et al. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease. Lancet 1994; 343: 1570.
27. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H et al. Inverse relationship between circulating oxidized low-density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 2000; 148: 171-7.